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This paper describes the role of mathematical modelling in the design and evaluation of an automated
system of wearable and environmental sensors called PAM (Personalised Ambient Monitoring) to
monitor the activity patterns of patients with bipolar disorder (BD). The modelling work was part of
an EPSRC-funded project, also involving biomedical engineers and computer scientists, to develop
a prototype PAM system. BD is a chronic, disabling mental illness associated with recurrent severe
episodes of mania and depression, interspersed with periods of remission. Early detection of the onset
of an acute episode is crucial for effective treatment and control. The aim of PAM is to enable patients
with BD to self-manage their condition, by identifying the person’s normal ‘activity signature’ and
thus automatically detecting tiny changes in behaviour patterns which could herald the possible onset of
an acute episode. PAM then alerts the patient to take appropriate action in time to prevent further
deterioration and possible hospitalisation. A disease state transition model for BD was developed, using
data from the clinical literature, and then used stochastically in a Monte Carlo simulation to test a wide
range of monitoring scenarios. The minimum best set of sensors suitable to detect the onset of acute
episodes (of both mania and depression) is identiﬁed, and the performance of the PAM system evaluated
for a range of personalised choices of sensors.
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Introduction
Bipolar disorder (BD) is a severe, chronic form of mental
illness associated with two types of recurrent episode,
mania and depression, both of which drastically affect
quality of life and the ability to function normally (Vojta
et al, 2001; Michalak et al, 2007). Patients with severe
BD often ﬁnd it difﬁcult to hold down a regular job or
maintain personal relationships. BD can lead to signiﬁ-
cant psychological, functional, occupational and cognitive
impairment. The illness is associated with high morbidity
and mortality: the mortality rate in BD is two to three
times higher in comparison with the general population
(Mu¨ller-Oerlinghausen et al, 2002; Belmaker, 2004). The
risk of relapse for a BD patient increases over time, and
can differ from a few weeks to many months. In a survival
analysis by Gitlin et al (1995), the risk of relapse was shown
as 73% within ﬁve years, and two-thirds of those who
relapsed suffered multiple relapses. The prevalence of BD is
increasing, and the age of onset is decreasing (Dienes et al,
2006). The prognosis for this disorder remains bleak, with
repeated severe episodes interspersed with mild but
signiﬁcant symptomatic periods (Solomon et al, 1995).
BD is associated with high social and health-care costs.
Higher dependence on public assistance (Judd and Akiskal,
2003) and increased health-care use and costs (Judd and
Akiskal, 2003; Simon, 2003) are found to be closely
associated with BD. The costs to society are considerable.
BD can lead to higher rates of unemployment (Tse and
Walsh, 2001), lower productivity and annual income
(Goetzel et al, 2003), higher work absenteeism (Simon,
2003; Goetzel et al, 2003), and episodic antisocial
behaviour (APA, 2000). The annual cost of managing
BD in the UK NHS in 1997–1998 was estimated to be
£199 million, of which £69 million was spent on hospital
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admissions (Gupta and Guest, 2002). Based on a total of
approximately 12400 hospital episodes for BD in that year,
this gives a rough average cost of over £5000 per admission
at 1998 prices (Gupta and Guest, 2002). About 10% of the
total NHS expenditure on BD is spent on medication and
about 90% is spent on hospital admissions. Many drugs
are available for the treatment of BD, but (in addition to
the unpleasant side-effects of these drugs) patients com-
monly experience multiple relapses and frequent oscilla-
tions in symptom severity, despite ongoing maintenance
therapy (Tohen et al, 2005). Pharmacological treatments
cannot control issues such as medication adherence, early
detection of acute episodes, self-awareness and coping
skills. Since drug treatment is only partially successful,
psychosocial interventions are often combined with main-
tenance pharmacotherapy to target all aspects of the
disorder and thus improve overall treatment outcome.
Surveys have shown that many BD patients are very
keen to use psychosocial therapy and self-management
approaches in addition to pharmacological treatment
(Lish et al, 1994; Hill et al, 1996).
However, despite its severely disabling nature, BD
can be managed effectively through self-monitoring. Many
BD patients are reportedly keen to monitor their condi-
tion regularly to minimise the severity of their episodes.
It is easier to treat milder symptoms in the early stage of
a relapse than more severe symptoms later in the relapse
(Morriss et al, 2007). The importance of analysing the early
warning signs of relapse is therefore clear: if BD patients
can recognise the signs early enough, actions can be taken
to avert the progress of a full-blown episode. Equally,
early symptoms of relapse are useful indicators to patients
themselves, family members or clinicians, since extra
support can then be provided to help prevent progression
into a full-blown episode. Each episode usually begins with
a similar pattern of symptoms (called prodromes) that is
distinctive for each individual; as such, it is often possible
to detect unexpected mood changes leading to an imminent
episode. Common prodromes of mania include decreased
need for sleep, increased activity, elevated mood and racing
thoughts and speech, while prodromes of depression
include interrupted sleep, decreased activity, empty mood
and loss of interest (Lam et al, 2001).
To date, most self-management interventions have been
manual and diary-based. These are not only time-consum-
ing and expensive, but are also unreliable. Moreover,
they are less accurate in detecting the onset of depression
(Perry et al, 1999). Patients have also been known to
fabricate diary entries immediately before a hospital visit,
and obviously under such circumstances their recall of
events may be incorrect and biased (Kobak et al, 2001).
Therefore, automated ambient data collection to identify
a BD patient’s daily activity patterns may avoid the
drawbacks of manual systems and moreover, may detect
both aspects of the disorder.
The PAM project
Personalised Ambient Monitoring (PAM) is a multi-
disciplinary EPSRC-funded project involving biomedical
engineers, operational researchers and computer scientists
at the Universities of Southampton, Nottingham, Stirling
and Warwick. The aim of the project was to develop an
automated system of unobtrusive sensors to monitor the
behaviour patterns of patients with BD, and hopefully
detect changes in these behaviour patterns that might
signal the early onset of an acute episode of illness. By then
issuing an alert to the patient, such an episode could
potentially be averted. The PAM system uses a system of
unobtrusive small wearable and environmental sensors to
monitor patients’ personal daily behaviour patterns. PAM
analyses the data from these to determine a normal
‘activity signature’, that is, a kind of ﬁngerprint of normal
daily activity. Having established a normal baseline activity
signature, PAM can then identify small changes, for
example minor unexplained disruptions in sleep or meal
patterns, which patients may not be aware of themselves
but which may potentially herald the early signs of an acute
episode.
The key aspect (the ‘P’ of PAM) is that the level of
monitoring that each person is comfortable with will be
different. The PAM system allows patients to adjust the
monitoring to suit their individual preferences. They can
switch individual sensors on or off, as they like, or even
switch the whole system off. PAM collects data from three
types of source. First, from sensors situated in the home
that collect information on light levels, sound levels,
movement information, and aspects of television usage.
Second, from sensors worn by the individual that detect
sound and light levels, movement, and position. Finally,
using a mobile phone the system collects information
from individuals on activities and mood.
The available sensors consist of a wearable device with a
microphone (which records sound features only, not actual
voice); the wearable also includes a GPS, light sensor and
accelerometer. It is comparable in size and weight to an
iPod or mobile phone, and any of the sensors on it can be
disabled. The ‘environmental’ sensors include PIR (passive
infra-red) devices, which only record presence/absence of
movement, like a household intruder detector; cameras
(which do not record or store images but merely the
presence/absence of moving objects); ambient microphones
(which record sound features only, not actual voice);
ambient light sensors (which detect levels of daylight/
artiﬁcial light); pressure mats (for detecting movements
through doorways, bedside mats etc); a TV remote monitor
(counts number of button presses only); read switches
(used on cupboard or fridge doors, to detect when door is
opened or closed); and bluetooth encounters (a device on
the PAM mobile phone to detect proximity to other
devices using bluetooth protocol, eg mobile phones).
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The data from all these sensors are analysed on
a dedicated PC in the patient’s home. A prototype PAM
system has been built by the engineers at the three partner
universities. Although a very small-scale feasibility study
was performed, and the researchers tested the technical
performance of the prototype system by monitoring
themselves, the PAM system is not yet sufﬁciently
developed to carry out a proper clinical trial with real
patients. The role of the Operational Research team was
therefore to develop a model which would enable the PAM
system to be tested ‘in silico’ for a wide range of potential
choices of sensors.
A natural history model for BD
Clinical diagnosis of mental disorders is very challenging.
Diagnosis is generally made on the basis of a conversation
(or series of conversations) between the patient and
an experienced clinical psychiatrist. No two patients will
describe exactly the same symptoms and there are no
universally accepted clinical staging models for mental
disorders, based on objective clinical measurements such
as tumour size, CD4 cell count or cholesterol levels,
as there are for most physical diseases. Most disease
models in the OR literature use recognised ‘compartments’
or stages which are deﬁned by these clinical markers and
have a clinical meaning. Thus it is far more difﬁcult to
develop mathematical models for the natural history of
mental disorders than it is for physical diseases, and the
literature reﬂects this. A literature search did not reveal a
single model for BD, although there are a number of
models for unipolar depression. One of the best-known
examples is Patten and Lee (2004, 2005) who developed
a Markov model to estimate the associations among
incidence and the incidence estimation and episode
duration and the number of depressed weeks reported in
the preceding year.
An Excel-based Markov state transition model was
developed for the basic disease process, combined with
Monte Carlo simulation for generating the stochastic
behaviour (in terms of daily activities) of the simulated
individuals, and the corresponding stochastic data col-
lected by the PAM system under a range of different
scenarios. The ﬁrst step was to study the clinical literature
to understand the natural history of BD, and thus deﬁne
the clinical states required for the Markov model. The next
stage was to embed this in a spreadsheet model which
represented the activity patterns of hypothetical patients,
and then model the collection of data from different
conﬁgurations of sensors and the subsequent analysis and
interpretation of these data by the PAM algorithms.
Based on the information found from the clinical
literature, and following discussions with the clinical
psychiatrist on the Steering Group, the progression of
BD is represented by a parameter l which can be
conceptualised as a measurement of a person’s mental
health status, similar to the Young Mania Rating Scale
(Young et al, 1978) and the Hamilton Depression Rating
Scale (Hamilton, 1960). Although in reality this parameter
is continuous, it is discretised in the spreadsheet model
so that l takes values in steps of 0.01 between 0.00 and
1.00. The time-step is one day, and each day the value of
l either stays the same or is incremented or decremented,
with a certain probability. We followed the clinical
literature (Kalbag et al, 1999; Bauer et al, 2005) to assign
values of l to different mental health states, as depicted in
Table 1.
In reality these transitions may be very subtle and
gradual. An individual may move almost imperceptibly
from the normal range to the depressed or manic range.
The time spent making this transition will of course vary
from individual to individual, and the boundaries between
the ‘gross’ states (Depressed, Normal and Manic) are
blurred. To test the PAM system, we required a natural
history model which represented an entire bipolar cycle,
that is, we needed to construct a complete and realistic
trajectory of an ‘archetypal’ BD patient including periods
of depression, mania and normal health. In the Monte
Carlo simulation, they are all subject to minor random
ﬂuctuation in order to create individual variability. Thus,
although all patients follow the same general pattern, as
depicted in Table 2 and based on the clinical literature
as described below, each individual has a slightly different
trajectory.
The model has a cycle length of 18 months (Angst and
Preisig, 1995). Patients start in a healthy state and the ﬁrst
acute episode is depression (Kinkelin, 1954; Kalbag et al,
1999; Perugi et al, 2000; Judd et al, 2002). The durations
of the episodes of depression and mania are taken from
Angst and Sellaro (2000), Judd et al (2002) and NCCMH
(2006). The durations of the symptom-free intervals
between episodes and the changes in polarity are taken
from Slater (1938), Kalbag et al (1999), Dunner et al (1979),
Judd et al (2002), and Paykel et al (2006).
It can be seen that the archetypal patient has a period of
depression between days 165 and 294, a period of mania
Table 1 Values of the parameter l and their clinical
interpretation
Value of l Clinical state Source
0.00–0.09 Severe depression Kalbag et al (1999)
0.10–0.19 Moderate depression Kalbag et al (1999)
0.20–0.39 Mild depression Bauer et al (2005)
0.40–0.60 Normal health Bauer et al (2005)
0.61–0.80 Mild mania Bauer et al (2005)
0.81–0.90 Moderate mania Kalbag et al (1999)
0.91–1.00 Severe mania Kalbag et al (1999)
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between days 459 and 546, and otherwise is normal.
Since the fundamental purpose of the model was to
evaluate the effectiveness of PAM in detecting the early
onset of an acute episode, the model includes an initial
Mild state, for both depression and mania, to test the
sensitivity of PAM in recognising the early signs when
intervention (in real life) would still be useful. If this is
not detected, the patient passes directly to the Severe
state. Thus the pattern is not strictly symmetrical, because
recovery occurs via the Moderate state, as would happen
in real life following a major episode.
Since all people (regardless of mental health status)
experience some ﬂuctuation in their mood from day to day,
the model then adds random noise within the ranges
depicted in Table 2, as depicted in Figure 1.
Modelling activity patterns
The next step was to develop a model for daily activity
patterns, based on this natural history model. A key
assumption of this model is that an individual’s daily
activity pattern is a function of two things: (a) his/her
mental health status, as deﬁned by l, and (b) a random
element totally unrelated to health. We have, therefore,
constructed a function which maps l onto a series of
observed activities (sleeping, talking, watching TV, etc) but
also includes a random aspect—for example, a patient may
watch less TV than usual on a particular day because
she/he is at the cinema, or has visitors, etc. This mapping
function is actually a slight simpliﬁcation of the real-life
PAM system as it omits part of the data processing that the
real PAM performs. The sensors in PAM do not directly
monitor a person’s observable behaviours, but just collect
a vast amount of raw data, such as the sound levels in
decibels in a particular room at 10-s intervals, which are
then translated into meaningful measures, such as the
average number of hours of sleep in a 24-h period, by
the use of intelligent feature extraction algorithms (Amor
and James, 2008).
The simulation model assumes that this feature extrac-
tion has already occurred and that it is possible to observe
meaningful behaviours, which may (or may not) have
clinical signiﬁcance in terms of BD. It also assumes that
these activity levels have been calibrated for each patient
in the normal, manic and depressed states. This is not a
restrictive assumption: most BD patients are very aware of
their own behaviour patterns in all three states. Moreover,
in a practical setting the PAM system would be calibrated
for a patient’s normal activity before use.
This mapping function has been modelled as follows.
For a given individual, let N, D and M be the average
levels of some particular variable (eg light levels in lux
in the kitchen at 4.00 am) in the normal, extremely
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The following function of the parameters l, N, D and M
was devised to calculate the value of this variable across
all possible mood states:






The form and parameters of this function are arbitrary,
and there is no signiﬁcance behind the choice of quadratic
or cubic powers of l. The function was chosen simply to
provide face validity with the interpretation of l, so that
it had the following required properties: when l¼ 0,
Equation (1) yields D (the value when fully depressed);
l¼ 0.5 gives N and l¼ 1 givesM. Intermediate values of l
give a smooth curve with the desired ‘mixed’ values,
corresponding to milder states of mania or depression, as
shown in Figure 2. Equation (1) is similar in structure
and in some detail to the expression utilised by Bauer
et al (2005). As before, in the Monte Carlo simulation
Equation (1) is not applied deterministically but is subject
to small random variation in the parameters N, D and M,
implemented in the model by sampling from a uniform
distribution. For example, a person who says they normally
sleep 7h a night may in practice sleep for anything between
6 and 8h, irrespective of their mental health status.
By way of illustration, consider sleep pattern, which is
known to be affected in BD (Morriss, 2004). Suppose that
over a 24-h period, a person sleeps (on average) for 6 h
when they are in good health, for 10h when they are very
depressed and for 4 h when they are very manic: thus
N¼ 6, D¼ 10 and M¼ 4. Figure 2 shows the mapping
between the mood states and hours of sleep. It can clearly
be seen from Figure 2 that the time spent asleep oscillates
on a daily basis, but overall decreases nonlinearly from N
to M as l increases from 0.5 to 1.0, and increases from N
to D as l decreases from 0.5 to 0.0, as would be expected,
since patients tend to sleep longer when depressed and less
when manic (Morriss, 2004).
Of course, observations such as disturbed sleep patterns
(although a recognised symptom in BD) may naturally
vary for reasons totally unrelated to mental health; thus we
cannot use the equation in a simplistic fashion to predict
or diagnose BD. Normal healthy people can still ﬁnd it
difﬁcult to sleep at times! Therefore, the PAM system does
not use a single behavioural measure to infer anything
about mental state, but rather, combinations of behaviours
repeated over several days.
The details of the model were discussed with a clinical
psychiatrist who treats many BD patients. Thus the
literature-based assumptions and parameters of the model
were augmented and validated with expert opinion.
Clearly, like any model this is an over-simpliﬁcation
of reality. Sensitivity analysis was performed to test the
robustness of the results to any estimated parameters, so
that areas of uncertainty were identiﬁed and the effect on
the results noted.
Modelling PAM-observable behaviours
In addition to the disease-related parameters discussed
above, the inputs to the model also include a selection of
the most common bipolar prodromes, together with
behavioural parameters and technical parameters relating
to the choice of sensors and the reliability and accuracy
of the PAM system. Self-reporting of daily sleep, activity
and mood ﬂuctuations is an established clinical tool for
the clinician to assess the severity of BD (Bauer et al, 1991;
Leverich and Post, 1996). The ﬁve most common bipolar
prodromes, derived from the clinical literature (WHO,
2001; Morriss, 2004), were mapped in the model to various
observable behaviours: these prodromes are activity levels,
sleep, talkativeness, social energy, and appetite. Other
prodromal symptoms are described in the literature but
were not included in PAM, either because they are hard
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Figure 1 A sample trajectory of BD deﬁned by small
ﬂuctuations of the parameter l.
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less common. These include ‘feeling in another world’
and ‘anxiety’, which may precede episodes of mania and
depression respectively (Morriss, 2004). Adherence to
medication is also clearly important but this could not be
monitored by the PAM system, which merely records
observable activity. Even putting a sensor on the lid of a
pill box, to record whether it had been opened, would not
necessarily guarantee that the patient had then swallowed
the tablets. We also had to exclude another important
prodrome—increased or decreased ‘interest in sex’—for
obvious ethical and privacy reasons!
The 14 PAM-observable behaviours, with units of
measurement shown in parentheses, are shown below.
These were mapped in the model to the above ﬁve
prodromes (see Figure 3).
(a) Daily activity (PAL). The PAL (Physical Activity
Level) is commonly used to express a person’s daily
physical activity, and is used to approximate a person’s
total energy expenditure (UNU, 1994). For example,
the PAL for an ofﬁce worker getting little or no
exercise ﬂuctuate between 1.4 and 1.7
(b) Earliest time person leaves home in the morning (time
of day)
(c) Latest time person gets back home in the evening (time
of day)
(d) Total number of TV remote keypresses (number)
(e) Total time spent in bed in a 24-h period (hours)
(f) Average light level between 11 pm and 7 am (lux)
(g) Average noise level between 11 pm and 7 am (decibels)
(h) Total time spent talking on the telephone (minutes)
(i) Total number of daily phone calls (number)
(j) Total time spent outside the home between 5 pm and
1 am (hours)
(k) Cupboard door usage (ie the total number of times the
doors were opened)
(l) Fridge door usage (ditto)
(m) Microwave door usage (ditto)
(n) Usual time the person cooks the evening meal (time
of day).
This choice of 14 observable behaviours was based entirely
on the capability of the PAM sensors selected in the real
system. Other observable behaviours such as ‘talking
speed’ or ‘spending habits’ could hypothetically have been
considered in the model, but none of the PAM sensors
can collect these types of information. Although obser-
vable behaviours such as ‘time spent talking on the
phone’ and ‘number of daily phone calls’ can be used as
proxies to indicate whether a person is talking more or
less than usual, obviously, ‘talking speed’ will not be
captured. This hierarchy of clinical prodromes, observable
behaviours and the sensor data is depicted in Figure 3.
The ﬁve prodromes deﬁned by psychiatrists and cited in
the literature are at the top level, with the 14 observable
behaviours at the next level down, and the sensor data
at the bottom level.
Some of the observable behaviours such as ‘time spent
in bed’ and ‘daily activity’ are generic (ie common to all
people), while behaviours such as ‘earliest time leaving
home in the morning’ and ‘usual time for cooking’ are
variable depending on a patient’s lifestyle, whether they live
on their own, go out to work, have an active social life,
cook for themselves, and so on. Following discussion
with the Steering Group, it was felt that the main use of
PAM would be for patients who live alone; although in
the technical trials of the equipment on members of the
research team (all of whom lived with several other people),
it was found to be possible to identify some data
by individual. By deﬁnition, in practice the PAM system
would be conﬁgured to suit the patient’s particular lifestyle,
and the activity patterns for an unemployed person would
obviously be different from the cases considered here.
Different people will have different sets of prodromes
that may indicate the onset of an acute episode. In reality,
people may have very personal and speciﬁc warning signs
activity level sleep talkativeness social energy appetite
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Figure 3 Mapping between prodromes, observable behaviours and sensors.
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of an episode, which apply only to them. Other patients
may know from their own personal experience that simul-
taneous changes in several different behaviours can
indicate the onset of an episode. A patient may know that
changes in both ‘activity level’ and ‘sleep’ mean that he/she
is going to have an episode. Obviously, if this patient is not
willing to have any sensors which monitor the observable
behaviours of ‘activity level’ and ‘sleep’, then PAM will not
work for him/her. Some people may object to a particular
sensor rather than the activity it is intended to monitor.
Figure 3 shows that there are several ways in which a
speciﬁc prodrome can be monitored. For example, sleep
patterns could be monitored by a pressure mat placed in
the bed which detects the presence or absence of a person
in the bed, or by a pressure mat placed on the ﬂoor by the
bed, or by light and/or sound levels in the bedroom.
A patient might object to the pressure mat in the bed but
be willing to have it on the ﬂoor. He/she may object to the
sound level sensor but be happy about the light sensor
(or vice versa). Another patient might object to having his
sleep habits monitored at all.
The model considers 25 different patient types, deﬁned
on the basis of the prodromes they were willing to be
monitored on rather than the individual sensors they were
willing to use. This was a pragmatic choice since the
potential number of combinations of sensors and different
locations within a person’s home is astronomically large.
Although the prodromes used in this research were selected
on the basis of the clinical literature, this is obviously by
no means an exhaustive set. However, 25 patient types
are more than sufﬁcient for the purposes of this analysis.
Patient types 1–10 chose a selection of two different
prodromes, patient types 11–19 chose a selection of three
different prodromes, patient types 20–24 chose a selection
of four different prodromes, and patient type 25 chose all
ﬁve prodromes.
The random element of each behaviour, that is the part
not dependent on mental health state but simply due
to daily variability, was modelled by ﬁtting triangular
probability distributions. There were no empirical data to
which to ﬁt these distributions, so they were determined by
a combination of common sense, practical experience and
some clinical input. The triangular distribution was chosen
as it is simple to parameterise and is widely used as
a subjective description of a population for which there
is only limited sample data, especially in cases where
the relationship between variables is known but data are
scarce. For values of some of the behavioural parameters,
for example the average number of phone calls a person
might make each day or the normal time they leave home
in the morning or cook their evening meal, we had to resort
to common sense. While there was evidence in the
literature about the importance of these behaviours, we
had no secondary or primary data on which to populate
the model.
Of course, the major source of uncertainty is the
functionality of the PAM system itself. Indeed this was
the prime motivation for the research in this paper.
Ambient data collection is inherently unreliable. The
sensors may malfunction or break down completely, there
may be a power loss, the patient may accidentally (or
deliberately) switch off the PC, or simply forget to recharge
the wearable device or the mobile phone. The patient may
damage, lose or switch off any of the sensors. There may be
software problems with the PC. In these circumstances,
PAM may report a change in behaviour which has not
taken place (a false positive) or miss a change which has
taken place (a false negative). Both of these are undesir-
able: clearly failing to issue an alert if a genuine change in
mental health state has occurred would render the whole
PAM system pointless, but on the other hand if the system
keeps issuing alerts when nothing is wrong then the patient
will quickly become disillusioned with PAM and will stop
using it.
Data errors caused by technical malfunction were
modelled by randomly modifying the relevant observed
behavioural parameter upwards or downwards by an
amount based on a combination of suggestions from the
technical members of the PAM team, and common sense.
To give an illustrative example, the sampled value of ‘Time
spent in bed’ was varied uniformly by70.5 h (ie730min).
Thus, if the actual sampled value for ‘Time spent in bed’
on some given day was 6h, then the PAM-detected
corresponding value would be a randomly chosen value
between 5.5 and 6.5 h. An example of this, for PAL, is
shown in Figure 4.
PAM decision rules
A key purpose of the model was to deﬁne effective decision
rules for identifying whether a signiﬁcant change in
behaviour had occurred, so that PAM would issue an
alert (ie send a text message) to the patient. Although there
was some guidance on this in the literature, as in the case
Figure 4 PAM detected physical activity levels during various
mood states.
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of the behaviours the main aim was to produce rules that
were simple, credible and practicable. The decision rules
and threshold levels were chosen using ideas from the
literature together with common-sense judgement, in order
to address the need for timely and accurate evaluation of
bipolar relapses. Morriss (2004) used the occurrence of
at least four out of a total of six prodromes to deﬁne
a danger level of relapse, with two or three as indicating
a warning level. We adopted a similar approach, assuming
that the simultaneous presence of any combination of
two or more of the ﬁve prodromal symptoms may trigger
an alert. However, we also assumed that not all the
corresponding observed behaviours need to occur in order
to indicate a prodrome. For example, the time a person
spends outside the home is not just associated with that
person’s ‘activity level’, but also with ‘sleep’ and ‘social
energy’. The existence of any two or more prodromes may
be sufﬁcient to indicate a potential relapse, and thus we set
a certain number of observed behaviours to be occurred at
a time to imitate its associated prodromes.
A value of 1 (¼ yes) was assigned when an observed
behaviour exceeded its speciﬁed threshold levels, and 0
(¼no) otherwise. Hence, the scoring system ranged from
0 to 14 since there are 14 observable behaviours. Hirschfeld
et al (2000) used a similar type of scoring system in
developing the Mood Disorder Questionnaire. To be
screened positive for a potential relapse, it is clearly not
mandatory to score the maximum 14 points. Different
values were tested in the simulation. The question remains
how long a person should persist with the prodromal
symptoms before receiving an alert, in order to minimise
the number of false alerts. Again, information from the
clinical literature was used to guide the choice. For
example, Keane (2010) reported that a manic patient did
not sleep for four successive days. In the ﬁrst set of
experiments, PAM sent an alert if the prodromal symp-
toms persisted for 3 out of 5 successive days. Table 3
(where A, B, . . . , G represent the observed behaviours)
shows an illustrative example of how such a decision rule
would work for a hypothetical patient who had chosen
to be monitored on ‘activity level’ and ‘sleep’ patterns.
The model was implemented in Microsoft Excel using
the Monte Carlo simulation add-in @Risk (Palisade,
2008). Since the true value of l is known in the model,
it is therefore possible to determine whether an alert
(if issued) was a true positive or a false positive, and
otherwise, if no alert was issued, whether this was a true
negative or a false negative.
Experimentation and results
Two data sets were used for experimentation, represent-
ing different patient groups corresponding roughly to
the clinical categories bipolar type I and bipolar type II.
Bipolar type I is more common, and involves severe mania
and depression, whereas type II involves severe depression
but only mild mania. Data set 1 contains patients who
typically show marked mood swings with a minimal
overlap with normality, whereas Data set 2 contains data
that overlap noticeably with normality. Intuitively, one
would expect PAM to work better for Data set 1 than for
Data set 2. For both cases, the model was run for 1000
iterations for each of the 25 hypothetical patient types, thus
simulating the disease trajectories of 1000 different patients
of each type.
Output from the model included the four most common
health-care technology evaluators, that is true positive
alerts (TP), false positive alerts (FP), true negatives (TN)
and false negatives (FN). In addition, the model computed
the average number of days that the PAM system took to
detect the onset of a depressive episode (ODE) and the
onset of a manic episode (OME). The ideal would be a very
low FP, a very high TP, and very low ODE and OME.
Although the PAM system did send some false alerts, these
were minimal in all cases. On the other hand, the TP rate
did not exceed 90% for any of the personalised prodromal
choices examined. This shows that the PAM system is not
biased towards keeping the FP values low.
The aim of the trials was to evaluate the performance of
PAM under various sensor conﬁgurations, corresponding
to an individual patient’s willingness to be monitored for
Table 3 An example of how the decision rules work





1 0 0 1 0 0 0 1 No No
2 1 0 0 1 0 1 0 No No
3 0 1 0 1 1 0 1 Yes No
4 1 0 1 0 1 1 0 Yes No
5 0 1 1 1 0 0 1 No No
6 1 1 0 0 1 1 1 Yes Yes
7 1 1 1 1 1 1 1 Yes Yes
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different combinations of prodromes. Conversely, it is also
of interest to investigate what sensors would be required in
order to provide information of a given quality to the
patient. In other words, the model results can be used
‘backwards’: the required performance criteria are now
deﬁned in advance, and the model used to determine which
sensor conﬁgurations meet these criteria. Following
discussions with the rest of the PAM team, it was decided
to set the following target performance criteria for PAM: a
minimum TP rate of 70%, a maximum FP rate of 3%,
a maximum ODE of 3 weeks and a maximum OME
of 2 weeks. Tables 4 and 5 show the smallest set of sensors
acceptable to patients in each category, in descending order
of TP values, which meet these target criteria.
Table 4 Acceptable choices in descending order of TPs (Data set 1)
Patient
types








Type 25 Activity level Sleep
Talkativeness Social energy
Appetite
Accelerometer; GPS; TV usage sensor; Pressure
mat; Light sensor; Microphone; Phone sensor;
Camera; Cupboard door sensors
05.90 02.64 87.48 2.12
Type 20 Activity level Sleep
Talkativeness Social energy
Accelerometer; GPS; TV usage sensor; Pressure
mat; Light sensor; Microphone; Phone sensor
08.10 03.12 85.22 0.85
Type 22 Activity level Sleep Social
energy Appetite
Accelerometer; GPS; TV usage sensor; Pressure
mat; Light sensor; Microphone; Camera;
Cupboard door sensors
08.17 03.54 84.16 1.30
Type 21 Activity level Sleep
Talkativeness Appetite
Accelerometer; GPS; TV usage sensor; Pressure
mat; Light sensor; Microphone; Phone sensor;
Camera; Cupboard door sensors
08.37 04.01 83.65 1.05
Type 24 Sleep Talkativeness Social
energy Appetite
GPS; Pressure mat; Light sensor; Microphone;
Phone sensor; Camera; Cupboard door sensors
11.14 03.43 82.54 0.92
Type 13 Activity level Sleep
Appetite
Accelerometer; GPS; TV usage sensor; Pressure
mat; Light sensor; Microphone; Camera;
Cupboard door sensors
10.99 05.63 78.49 0.70
Type 23 Activity level Talkativeness
Social energy Appetite
Accelerometer; GPS; TV usage sensor; Phone
sensor; Camera; Cupboard door sensors
15.97 04.70 77.23 1.19
Type 12 Activity level Sleep Social
energy
Accelerometer; GPS; TV usage sensor; Pressure
mat; Light sensor; Microphone
20.83 04.81 76.42 0.45
Type 11 Activity level Sleep
Talkativeness
Accelerometer; GPS; TV usage sensor; Pressure
mat; Light sensor; Microphone; Phone sensor
18.82 06.33 75.99 0.45
Type 18 Sleep Talkativeness
Appetite
Pressure mat; Light sensor; Microphone; Phone
sensor; Camera; Cupboard door sensors
6.73 06.54 75.78 0.42
Type 15 Activity level Talkativeness
Appetite
Accelerometer; GPS; TV usage sensor; Camera;
Cupboard door sensors
21.08 09.71 70.40 0.56
Table 5 Acceptable choices in descending order of TPs (Data set 2)
Patient
types








Type 25 Activity level Sleep
Talkativeness Social energy
Appetite
Accelerometer; GPS; TV usage sensor; Pressure
mat; Light sensor; Microphone; Phone sensor;
Camera; Cupboard door sensors
11.33 07.49 78.19 0.70
Type 20 Activity level Sleep
Talkativeness Social energy
Accelerometer; GPS; TV usage sensor; Pressure
mat; Light sensor; Microphone; Phone sensor
12.77 07.58 77.29 0.51
Type 21 Activity level Sleep
Talkativeness Appetite
Accelerometer; GPS; TV usage sensor; Pressure
mat; Light sensor; Microphone; Phone sensor;
Camera; Cupboard door sensors
14.45 08.37 76.55 0.60
Type 22 Activity level Sleep Social
energy Appetite
Accelerometer; GPS; TV usage sensor; Pressure
mat; Light sensor; Microphone; Camera;
Cupboard door sensors
16.77 13.43 73.80 0.50
Type 13 Activity level Sleep
Appetite
Accelerometer; GPS; TV usage sensor; Pressure
mat; Light sensor; Microphone; Camera;
Cupboard door sensors
20.73 15.76 71.71 0.44
Type 24 Sleep Talkativeness Social
energy Appetite
GPS; Pressure mat; Light sensor; Microphone;
Phone sensor; Camera; Cupboard door sensors
21.42 12.74 70.78 0.34
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The results showed that the PAM system can offer a
wider set of personalised prodromal choices to patients
who fall into Data set 1 than into Data set 2. The PAM
system was able to detect both aspects of BD, but was
more efﬁcient in detecting the onset of manic relapse than
depressive relapse. This is in accordance with clinical
experience. Nevertheless, PAM was still able to detect the
onset of depressive relapse early enough for various
personalised prodromal choices. More challenging perfor-
mance criteria, for example a minimum TP rate of 75%, a
maximum FP rate of 1%, 2 weeks for ODE and one week
for OME, are still achievable although not in quite so
many cases.
In comparison with Data set 1, there will indisputably
be less variability in Data set 2 between normal and
abnormal data. Thus, we would expect that it would be
more difﬁcult to detect the onset of acute episodes with
such patients. We would not only expect fewer true
and false alerts (TPs and FPs), but also greater delays in
detecting the onset of depressive and manic episodes
(ODEs and OMEs). This can indeed be seen from the
model results (see Figures 5–8).
Discussion
The overall performance of the PAM system was found
to be inadequate for almost all the personalised choices
of two prodromes only. This was not surprising, because
the clinical literature suggests it is difﬁcult to conﬁrm a
relapse with the appearance of only two prodromal
symptoms. The performance of the system was found to
be efﬁcient for various personalised choices of three
prodromes. However, the system was found to be less
effective for a few speciﬁc combinations of personalised
prodromal choices, for example ‘sleep’, ‘talkativeness’
and ‘social energy’, or ‘talkativeness’, ‘social energy’ and
‘appetite’, because these prodromes were associated with
relatively few observable behaviours. To be able to
effectively offer choices such as these, the PAM system
would need to increase the number of their associated
observable behaviours. This will not only improve the
performance of these particular choices, but will also
improve the performance of other choices.
BD is a multi-dimensional and extremely complex
illness, and clearly this model is a huge oversimpli-
ﬁcation. For example, BD is now clearly understood by
psychiatrists to have mixed episodes as well as the simple
Figure 5 Comparison of true positives (TP) between Data set 1
and Data set 2.
Figure 6 Comparison of false positives (FP) between Data set
1 and Data set 2.
Figure 7 Comparative time to onset of a depressive episode
(ODE) between Data sets 1 and 2.
Figure 8 Comparative time to onset of a manic episode (OME)
between Data sets 1 and 2.
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one-dimensional spectrum from depression to mania.
Moreover, clinical evidence suggests there are as many
different patterns of BD as there are humans suffering
from it, and to assume that this can be modelled by a single
‘archetypal’ disease trajectory (albeit with some random
variation in timing, duration and intensity of episodes)
is arguably a limiting assumption. We did attempt to
mitigate this by modelling the two different clinical data
sets. Nevertheless, the disease state transition model is ﬁt
for the intended purpose of this research, in the sense of
providing an adequate description of the natural history
of BD within which to test the PAM system.
Many other model assumptions, such as the choice
of triangular distributions for the activity patterns, could
have been made more realistic had empirical data been
available and other distributions ﬁtted. One obvious
drawback of the triangular distribution is that it does not
allow the sampling of extreme values. However, this was
not felt to be a severely limiting assumption for the
behavioural variables. The derivation of Equation (1), and
the mapping from l to the generated behaviour using the
parameters N, M and D, was again chosen somewhat
arbitrarily and clearly other functions could have been
used. Once again, we were restricted by the absence of
empirical data and the total absence in the literature of any
kind of similar research. Equation (1) and the subsequent
addition of random noise to the generated values
were adequate for their intended purpose, and the mapp-
ing from l to a behaviour value matched both clinical
experience and common sense.
The model showed that an automated ambient self-
monitoring system like PAM can be adjusted and
personalised, and can be offered as a direct motivator for
behavioural change in bipolar patients. Through PAM, it is
possible to provide useful information about a patient’s
mental health status. The modelling component of the
PAM project showed that it is possible to send timely alerts
of an imminent bipolar episode through integrating
behavioural signatures into a patient’s health-care plan.
The model tested the capability of the PAM system to
produce reliable results in a real-life situation from a
limited set of sensors. The system could therefore provide
health-care professionals with additional clinical informa-
tion to beneﬁt bipolar patients. The overall performance
of PAM was found to be good enough to support the need
for further trialling, and the next steps are clearly to
proceed to a larger-scale clinical trial.
Hopefully, in future BD patients and their families will
ﬁnd PAM reliable, simple to use and effective in improv-
ing quality of life while at the same time reducing costs
by preventing unnecessary hospital admissions. The
same technology could also be applicable to other patient
groups, for example schizophrenia or dementia. The
modelling approach could also be used in many other
situations where remote monitoring is required.
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